Pieter M. Jansen

ORCID: 0000-0003-4416-0287
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hormonal Regulation and Hypertension
  • Adrenal and Paraganglionic Tumors
  • Blood Pressure and Hypertension Studies
  • Adrenal Hormones and Disorders
  • Cardiovascular, Neuropeptides, and Oxidative Stress Research
  • Electrolyte and hormonal disorders
  • Pituitary Gland Disorders and Treatments
  • Renin-Angiotensin System Studies
  • Sodium Intake and Health
  • Ion Transport and Channel Regulation
  • Digital Mental Health Interventions
  • Glioma Diagnosis and Treatment
  • Diabetes Management and Education
  • Mobile Health and mHealth Applications
  • Vitamin K Research Studies
  • Cerebrospinal fluid and hydrocephalus

Princess Alexandra Hospital
2018-2023

The University of Queensland
2018

Erasmus University Rotterdam
2007-2013

Erasmus MC
2007-2012

Aarhus University
2012

Unilateral primary aldosteronism is the most common surgically correctable form of endocrine hypertension and usually differentiated from bilateral forms by adrenal venous sampling (AVS) or computed tomography (CT). Our objective was to compare clinical biochemical postsurgical outcomes patients with unilateral diagnosed CT AVS identify predictors surgical outcomes. Patient data were obtained 18 internationally distributed centers retrospectively analyzed for adrenalectomy management based...

10.1161/hypertensionaha.118.11382 article EN Hypertension 2018-07-09

Urinary exosomes are vesicles derived from renal tubular epithelial cells. Exosomes often contain several disease-associated proteins and thus useful targets for identifying biomarkers of disease. Here, we hypothesized that the phosphorylated (active) form sodium chloride cotransporter (pNCC) or prostasin could serve as aldosteronism. We tested this in 2 animal models aldosteronism (aldosterone infusion low-sodium diet) patients with primary were isolated 24-hour urine spot using...

10.1161/hypertensionaha.112.198135 article EN Hypertension 2012-07-31

The aim of this study was to investigate the aldosterone–angiotensin (Ang) II interaction in human coronary microarteries (HCMAs). HCMAs, obtained from 75 heart-beating organ donors, were mounted myographs and exposed Ang II, either directly or following a 30-min pre-incubation with aldosterone, 17β-oestradiol, hydrocortisone, p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580, extracellular regulated 1/2 (ERK1/2) PD98059, GPR30 antagonist G15, epidermal growth factor receptor...

10.1093/cvr/cvs016 article EN Cardiovascular Research 2012-01-18

The aldosterone-to-renin ratio (ARR) is a widely used screening test for primary aldosteronism. Current guidelines recommend cut-off value of 91 pmol/mU. Studies on its sensitivity, specificity, reproducibility and the role medication have been conflicting. We prospectively assessed characteristics ARR effect combination antihypertensive treatment.In 178 patients with persistent hypertension despite use at least two antihypertensives, plasma renin aldosterone were twice within an interval 4...

10.1097/hjh.0b013e3283656b54 article EN Journal of Hypertension 2013-09-07

To test whether glucocorticoids act as the endogenous agonist of cardiac mineralocorticoid receptors, we evaluated effects aldosterone and corticosterone steroidogenesis vs. steroid uptake from plasma.Both increased left ventricular pressure in rat heart. Aldosterone decreased coronary flow, whereas it. All were blocked by glucocorticoid receptor antagonist, RU486, unaltered canrenoate, or 11beta-hydroxysteroid dehydrogenase (HSD11B)2 inhibitor, carbenoxolone. Unlike blockade, RU486 did not...

10.1097/hjh.0b013e328335c381 article EN Journal of Hypertension 2010-03-23

Background: Add-on therapy with aldosterone receptor antagonists has been reported to lower blood pressure (BP) in patients uncontrolled hypertension. We assessed potential predictors of this response. Methods: In essential hypertensive BP, despite the use at least two antihypertensives, plasma renin and concentrations transtubular potassium gradient (TTKG) were measured. Patients treated eplerenone 50 mg daily on top their own medication. The office ambulatory BP response biochemical...

10.1097/hjh.0b013e32835b71d6 article EN Journal of Hypertension 2012-12-19

Introduction: Transgenic rats expressing the human (pro)renin receptor (h(P)RR) have elevated plasma aldosterone levels despite unaltered levels, in and adrenal, of renin angiotensin II. Materials methods: To investigate whether renin/prorenin–(P)RR interaction underlies these effect on steroidogenesis was compared with that II two (P)RR-expressing adrenocortical cell lines, H295R HAC15. Angiotensin rapidly induced extracellular signal-regulated kinase (ERK) phosphorylation increased...

10.1177/1470320312438792 article EN Journal of the Renin-Angiotensin-Aldosterone System 2012-03-06

Background . The long-term efficacy of aldosterone-receptor antagonists (ARAs) as add-on treatment in uncontrolled hypertension has not yet been reported. Methods Data from 123 patients (21 with primary aldosteronism, 102 essential hypertension) difficult-to-treat who received an ARA between May 2005 and September 2009 were analyzed retrospectively for their blood pressure (BP) biochemical response at first followup after start the last follow-up available. Results Systolic BP decreased...

10.4061/2011/368140 article EN cc-by International Journal of Hypertension 2011-01-01

Jansen, P. M.; Verdonk, K.; Imholz, B. P.; Danser, A. H.J.; van den Meiracker, H. Author Information

10.1097/00004872-201106001-00234 article EN Journal of Hypertension 2011-06-01

Jansen, P. M.; Danser, A. H.J.; Van Den Meiracker, H. On behalf of the Dutch Arrat Investigators Author Information

10.1097/00004872-201106001-01560 article EN Journal of Hypertension 2011-06-01

Background: Studies in transgenic rats expressing the human (pro)renin receptor have shown elevated plasma aldosterone levels these animals despite unaffected renin concentration or activity. It has been speculated that this is mediated through a direct effect of on synthesis via ((P)RR). Other studies an increased expression adrenal CYP11B2 mRNA compared to wildtype unchanged angiotensin II (Ang II). We evaluated main steroidogenic enzymes adrenocortical cell line (H295R). Methods: First,...

10.1097/01.hjh.0000379381.17759.a2 article EN Journal of Hypertension 2010-06-01

Aim: To determine what patients with uncontrolled hypertension benefit most from add-on therapy eplerenone. Methods: Essential hypertensives (n=117) blood pressure (BP) despite the use of at least two antihypertensive drugs were treated eplerenone 50 mg on top their own medication. Primary aldosteronism was excluded in all by a salt loading test. BP response and biochemical changes evaluated after 3 months treatment 6 weeks stopped (ES). Potential predictors for change 24-hours ambulatory...

10.1097/01.hjh.0000420651.04569.3e article EN Journal of Hypertension 2012-09-01

Background: The aldosterone-to-renin ratio (ARR) is a widely used screening test for primary aldosteronism (PA). A commonly adopted cut-off value 91 pmol/mU. However, its sensitivity, specificity, and reproducibility have not been studied extensively. Aim: To characterize the main characteristics of ARR. Design methods: In 179 patients with persistent hypertension despite use at least 2 antihypertensive drugs plasma renin aldosterone were assessed twice an interval to 4 weeks. All underwent...

10.1097/01.hjh.0000420652.81697.b3 article EN Journal of Hypertension 2012-09-01
Coming Soon ...